Search
for
Sort by
Research 30 of 1000+
- Air Pollution, Autophagy, and Skin Aging: Impact of Particulate Matter (PM10) on Human Dermal Fibroblasts
- The silver locus product (Silv/gp100/Pmel17) as a new tool for the analysis of melanosome transfer in human melanocyte–keratinocyte co‐culture
- Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice
- Topobiology of Human Pigmentation: P-Cadherin Selectively Stimulates Hair Follicle Melanogenesis
- Effect of a novel steroid (PM-9) on the inhibition of 5α-reductase present in Penicillium crustosum broths
- Pmg-1 and Pmg-2 constitute a novel family of KAP genes differentially expressed during skin and mammary gland development
- Fernblock® Upregulates NRF2 Antioxidant Pathway and Protects Keratinocytes from PM<sub>2.5</sub>-Induced Xenotoxic Stress
- pMB FLASH - Status and Perspectives of Combining Proton Minibeam with FLASH Radiotherapy
- Depletion of <i>Gsdma1/2/3</i> alleviates PMA-induced epidermal hyperplasia by inhibiting the EGFR–Stat3/Akt pathway
- Abnormal hair growth in patients (pts) with metastatic colorectal cancer (mCRC) treated with the anti-epidermal growth factor receptor (EGFr) monoclonal antibody (mAb) panitumumab (Pmab)
- Permanent Makeup (PMU) Removal with Plant Origin Extracts
- 5 alpha-reductase inhibition by a new synthetic steroid (PM-9) in cultures of Penicillium crustosum.
- Regulatory Effect of Cannabidiol (CBD) on Decreased β-Catenin Expression in Alopecia Models by Testosterone and PMA Treatment in Dermal Papilla Cells
- Why Permanent Makeup (PMU) Is Not a Lifetime Application
- Beyond Hirsutism: Hair Phenotypes as Clinical Signals for the Recognition of Polyendocrine Metabolic Ovarian Syndrome (PMOS): A Scoping Review Protocol
- THE IMPACT OF LIFESTYLE: THE EFFECTS OF DIET, EXERCISE AND INOSITOL SUPPLEMENTATION ON THE COURSE OF POLYENDOCRINE METABOLIC OVARIAN SYNDROME (PMOS): NARRATIVE REVIEW
- From PCOS to PMOS: The Impact of Physical Activity, Diet, and Metabolic Health on the Course of Polyendocrine Metabolic Ovarian Syndrome
- Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making
- ARTIFICIAL INTELLIGENCE AND THE DIAGNOSTIC INVISIBILITY OF WOMEN’S METABOLIC DISORDERS: A NARRATIVE REVIEW OF SOCIO-TECHNICAL CHALLENGES IN PCOS/PMOS RECOGNITION
- A practical guide on Polyendocrine Metabolic Ovarian Syndrome (PMOS) for Clinicians
- Evaluation of the Therapeutic Effect of Palash Basti in the Polyendocrine metabolic ovarian syndrome (PMOS): A Case Report
- Anti-Müllerian Hormone and Ovarian Morphology in Polycystic Ovary Syndrome (PCOS)/Polyendocrine Metabolic Ovarian Syndrome (PMOS): Toward More Precise Diagnosis and Phenotype Stratification
- From Reproductive Disorder to Metabolic Syndrome: The Evolution of Polycystic Ovary Syndrome (PCOS) into Polyendocrine Metabolic Ovarian Syndrome (PMOS)
- Redefining Polycystic Ovary Syndrome (PCOS) as Polyendocrine Metabolic Ovarian Syndrome (PMOS): Implications for Diagnosis, Pathophysiology and Clinical Management
- JUMLAH SEL PMN, MN, FIBROBLAS, ANGIOGENESIS PADA MENCIT DM YANG DIINDUKSI ALLOXAN
- PMON225 Androgen excess in pre-menopausal women due to Granulosa Cell tumor: A case report.
- PMON325 Rare Presentation of Precocious Puberty Secondary to LH-Secreting Adenoma
- PMON319 A Pure Androgen Secreting Adrenal - Cortical Tumor in a 13 Year Old Female
- PMON281 PERSISTENT VIRILIZATION AND VASOMOTOR SYMPTOMS IN A TRANSMAN 5-YEARS POST TESTOSTERONE WITHDRAWAL
- PMON224 Newly Observed Interference of Oral Biotin with the Free Testosterone Assay? In a Woman with Postmenopausal Virilization.